Cited by 240Barrier Structure and Function StudiesCholesterol and Lipid MetabolismDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 1 of the 28 sources its claims cite were checked for support.

Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes.

Open access
Dehouck, B, Dehouck, M P, Fruchart, J C, Cecchelli, R·1994·The Journal of cell biology

Abstract

In contrast to the endothelial cells in large vessels where LDL receptors are downregulated, brain capillary endothelial cells in vivo express an LDL receptor. Using a cell culture model of the blood-brain barrier consisting of a coculture of brain capillary endothelial cells and astrocytes, we observed that the capacity of endothelial cells to bind LDL is enhanced threefold when cocultured with astrocytes. We next investigated the ability of astrocytes to modulate endothelial cell LDL receptor expression. We have shown that the lipid requirement of astrocytes increases the expression of endothelial cell LDL receptors. Experiments with dialysis membranes of different pore size showed that this effect is mediated by a soluble factor(s) with relative molecular mass somewhere between 3,500 and 14,000. Substituting astrocytes with smooth muscle cells or brain endothelium with endothelium from the aorta or the adrenal cortex did not enhance the luminal LDL receptor expression on endothelial cells, demonstrating the specificity of the interactions. This factor(s) is exclusively secreted by astrocytes cocultured with brain capillary endothelial cells, but it also upregulates the LDL receptor on other cell types. This study confirms the notion that the final fine tuning of cell differentiation is under local control.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Brain capillary endothelial cells express LDL receptors at confluence despite high lipoprotein levels, unlike aortic endothelial cells, and coculture with astrocytes increases their LDL binding capacity. Astrocytes depleted of cholesterol release a soluble factor(s) of 3,500–14,000 mol wt that upregulates endothelial LDL receptor expression via new receptor synthesis.

Key findings

  • LDL binding to brain capillary endothelial cells was enhanced threefold when cocultured with astrocytes; maximal binding was 358 ng LDL/mg protein with astrocytes versus 215 ng LDL/mg protein without, with apparent Kd values of 43 nM versus 90 nM, respectively.
  • Cholesterol depletion of astrocytes by 36 h in lipoprotein-deficient serum decreased astrocyte cholesterol content by 32% (27.00 ± 3.37 vs 39.25 ± 4.03 µg cholesterol/mg protein, n = 6) and led to upregulation of endothelial LDL receptors, reaching a maximum of 600% of control binding at 4–5 h.
  • Astrocyte-conditioned medium increased LDL binding by 300% at 4–5 h; upregulation occurred with a 14,000 mol wt cutoff dialysis membrane but not with a 3,500 cutoff, indicating a soluble factor(s) between 3,500 and 14,000 mol wt.
  • The effect was specific: substituting astrocytes with smooth muscle cells or brain endothelium with aortic or adrenal cortex endothelium did not enhance luminal LDL receptor expression; acetylated LDL/scavenger receptor binding was not upregulated, and cycloheximide blocked the increase, indicating new LDL receptor synthesis.

Methods

  • Bovine brain capillary endothelial cells were cocultured with rat astrocytes on opposite sides of collagen-coated filter inserts; astrocytes were >95% GFAP positive. Bovine aortic endothelial cells, adrenal cortex endothelial cells, and smooth muscle cells were used for specificity comparisons.
  • LDL binding was performed at 4°C with [125I]LDL, with nonspecific binding determined by 20-fold excess unlabeled LDL; Scatchard analysis, C7 monoclonal antibody blocking, acetylated LDL binding, and HPLC cholesterol measurement were used.
  • Regulation experiments followed four phases: 12 d coculture in 15% calf serum, 36 h astrocyte incubation in 10% lipoprotein-deficient serum, induction with cholesterol-depleted astrocytes or conditioned medium at 37°C, then LDL binding at 4°C; dialysis membranes with 3,500 or 14,000 mol wt cutoffs and cycloheximide (10 µg/ml) were used in modified induction experiments.

Limitations

  • The paper states that the chemical nature of the astrocyte-regulating LDL receptor factor(s) is under investigation, that additional studies are underway to determine whether bound lipoproteins are degraded or transcytosed, and that 36 h LPDS incubation was used because cell lysis could be detected after 48 h.
  • The paper also notes that upregulation was lower with astrocyte-conditioned medium, possibly because the secreted molecule(s) is unstable.
  • Evident from the text: the findings rely on an in vitro bovine/rat coculture model, the soluble factor is not purified or chemically identified, and in vivo confirmation is not provided.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1083/jcb.126.2.465

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Experimental procedure for the upregulation experiments. The induction of LDL receptor expression can be described in four phases: (Coculture phase) Brain capillary ECs and astrocytes were cocultured for 12 d in DME supplemented with 15 % CS. (Astrocyte LPDS phase) ECs were transferred and cocultured with other astrocytes in DME supplemented with 15 % CS. Astrocytes of the initial coculture were incubated for 36 h at 37°C with DME supplemented with 10% LPDS, 2 mM glutamine, and 50 μg/ml gentamycin. As a control, the incubation of astrocytes was performed with DME supplemented with 10% FCS. (Induction phase) On the day of the experiment, brain capillary ECs in DMEM supplemented with 15 % CS were cocultured for different times at 37ºC with cholesterol-depleted astrocytes in their 36-h LPDS incubating medium. (LDL Binding phase) After the induction phase, specific [125I]LDL binding to ECs was performed at 4°C, at the concentration of 45 μg/ml of [125I]LDL as described under the experimental procedures. , DME + 15% CS; , DME + 10% LPDS;∞∞, brain capillary endothelial cells (BCECs); , astrocytes.
Figure 1 Experimental procedure for the upregulation experiments. The induction of LDL receptor expression can be described in four phases: (Coculture phase) Brain capillary ECs and astrocytes were cocultured for 12 d in DME supplemented with 15 % CS. (Astrocyte LPDS phase) ECs were transferred and cocultured with other astrocytes in DME supplemented with 15 % CS. Astrocytes of the initial coculture were incubated for 36 h at 37°C with DME supplemented with 10% LPDS, 2 mM glutamine, and 50 μg/ml gentamycin. As a control, the incubation of astrocytes was performed with DME supplemented with 10% FCS. (Induction phase) On the day of the experiment, brain capillary ECs in DMEM supplemented with 15 % CS were cocultured for different times at 37ºC with cholesterol-depleted astrocytes in their 36-h LPDS incubating medium. (LDL Binding phase) After the induction phase, specific [125I]LDL binding to ECs was performed at 4°C, at the concentration of 45 μg/ml of [125I]LDL as described under the experimental procedures. , DME + 15% CS; , DME + 10% LPDS;∞∞, brain capillary endothelial cells (BCECs); , astrocytes.CC BY-NC-SA · From the PDF
Figure 2 (a) Phase contrast micrograph of confluent brain capillary endothelial cells grown on the upper face of a collagen-coated filter. (b) Immunolabeling of a coculture of astrocytes with the antiGFAP serum. Bars, 30 μm.
Figure 2 (a) Phase contrast micrograph of confluent brain capillary endothelial cells grown on the upper face of a collagen-coated filter. (b) Immunolabeling of a coculture of astrocytes with the antiGFAP serum. Bars, 30 μm.CC BY-NC-SA · From the PDF
Figure 3 LDL binding to endothelial cells. Brain capillary ECs were cultured in the presence (O) or in the absence (·) of astrocytes for 12 d in DME supplemented with 15 % CS. LDL binding was performed on ECs at 4°C as described under the experimental procedures. These data are compared with LDL binding on confluent aortic ECs (∆). (Inset) Scatchard analysis of the binding data to brain capillary ECs. B, bound; B/F, bound/free.
Figure 3 LDL binding to endothelial cells. Brain capillary ECs were cultured in the presence (O) or in the absence (·) of astrocytes for 12 d in DME supplemented with 15 % CS. LDL binding was performed on ECs at 4°C as described under the experimental procedures. These data are compared with LDL binding on confluent aortic ECs (∆). (Inset) Scatchard analysis of the binding data to brain capillary ECs. B, bound; B/F, bound/free.CC BY-NC-SA · From the PDF
Image 4
CC BY-NC-SA · From the PDF
Figure 5 Upregulation of LDL receptor on brain capillary ECs. Specific binding of LDL at 4°C to brain capillary ECs: the upregulation was performed as described in Fig. 1, with astrocytes fed for 36 h with LPDS (). The control was the binding of LDL to ECs cocultured with astrocytes fed with serunt (), during the "astrocyte LPDS phase." The curves are representative of six series of independent experiments.
Figure 5 Upregulation of LDL receptor on brain capillary ECs. Specific binding of LDL at 4°C to brain capillary ECs: the upregulation was performed as described in Fig. 1, with astrocytes fed for 36 h with LPDS (). The control was the binding of LDL to ECs cocultured with astrocytes fed with serunt (), during the "astrocyte LPDS phase." The curves are representative of six series of independent experiments.CC BY-NC-SA · From the PDF
Image 6
CC BY-NC-SA · From the PDF
Figure 7 Preliminary characterization of soluble factor(s) secreted by astrocytes. Specific binding of LDL at 4°C to brain capillary ECs: the upregulation was performed as described in Fig. 1, but during the induction phase the two cell types were separated by cut off dialysis bags of 3,500 or 14,000 mol wt. BCECs were incubated during the induction phase with astrocytes fed with LPDS, with or without a dialysis bag (ø), or with astrocytes fed with FCS () as a control. The results are representative of two series of independent experiments.
Figure 7 Preliminary characterization of soluble factor(s) secreted by astrocytes. Specific binding of LDL at 4°C to brain capillary ECs: the upregulation was performed as described in Fig. 1, but during the induction phase the two cell types were separated by cut off dialysis bags of 3,500 or 14,000 mol wt. BCECs were incubated during the induction phase with astrocytes fed with LPDS, with or without a dialysis bag (ø), or with astrocytes fed with FCS () as a control. The results are representative of two series of independent experiments.CC BY-NC-SA · From the PDF
Figure 8 Interaction between brain capillary ECs and astrocytes during the "coculture phase." The upregulation was performed as described in Fig. 1, but astrocytes depleted in cholesterol were not cocultured with BCECs; they were cultured alone. Specific [125I]LDL binding was performed to BCECs incubated with astrocytes either cocultured with BCECs (0) or cultured alone (●).
Figure 8 Interaction between brain capillary ECs and astrocytes during the "coculture phase." The upregulation was performed as described in Fig. 1, but astrocytes depleted in cholesterol were not cocultured with BCECs; they were cultured alone. Specific [125I]LDL binding was performed to BCECs incubated with astrocytes either cocultured with BCECs (0) or cultured alone (●).CC BY-NC-SA · From the PDF
Image 9
CC BY-NC-SA · From the PDF
Image 10
CC BY-NC-SA · From the PDF

Verification

Claims the paper makes

30 Own result · 27 Own interpretation · 10 No full text of the sources · 9 Sources not found · 4 Not checked yet · 2 Own method · 2 No basis given · 1 Partly supported · accuracy not yet measured

Verify all 4 references — free account
  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 15
26 of 26
  • The paper relies on this without support.

    Aortic endothelial cells and smooth muscle cells have no intracellular pool of LDL receptor.

    “aortic ECs and smooth muscle cells have no intracellular pool of LDL receptor”
  • The paper relies on this without support.

    Astrocytes are capable of influencing the differentiation of brain endothelial cells in culture, as they are in vivo.

    “It is well known that astrocytes are capable of influencingthe differentiationofbrain ECs in culture, as they are in vivo.”
  • The paper relies on this without support.

    The direct action of LPDS on endothelial cells is well known, and lipoprotein receptor activity of endothelial cells is upregulated by exposure to LPDS after a minimum of 24 h.

    “the direct action of LPDS on endothelial cells is very well known, and lipoprotein receptor activity of EC is up- regulated by exposure to LPDS after a minimum of 24 h.”
  • The paper relies on this without support.

    Cycloheximide inhibits peptidyl transferase on the eukaryotic large ribosomal subunit and therefore protein synthesis in the cell.

    “Cycloheximide, known to inhibit peptidyl transferase on eu- karyiotic large ribosomal subunit, and therefore protein syn- thesis in the cell”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Cited by

Sorted by citations

See all 240

Metadata

Authors
Dehouck, B., Dehouck, M. P., Fruchart, J. C., & Cecchelli, R.
Affiliations
Inserm (FR)
Venue
The Journal of cell biology
Published
1994-07-15
Volume
126
Issue
2
Pages
465-473
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2159464926
Cited by
240
References
34
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 3 · 2018: 5 · 2017: 10 · 2016: 7 · 2015: 7 · 2014: 11 · 2013: 13 · 2012: 7
FWCI
7.04
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Cell Biology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
LDL receptor, blood-brain barrier, brain microvascular endothelial cells, astrocytes, LDL binding, soluble factors, receptor up-regulation, cell differentiation
MeSH terms
Adrenal Cortex, Animals, Aorta, Astrocytes, Binding Sites, Biological Factors, Blood-Brain Barrier, Brain, Capillaries, Cattle, Cell Communication, Cholesterol, Endothelium, Vascular, Kinetics, Lipoproteins, LDL, Muscle, Smooth, Receptors, LDL, Up-Regulation, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review